Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6a74173ab17e335bd3a6b21fffb1f021 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4985 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 |
filingDate |
2006-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e7860ff452542fff8330282b2a0fbad |
publicationDate |
2008-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2008306094-A1 |
titleOfInvention |
Combination of Azd2171 and Pemetrexed |
abstract |
The present invention relates to a method for the production of an antiangiogenic and/or vascular permeability reducing effect in a warm-blooded animal such as a human which is optionally being treated with ionising radiation, particularly a method for the treatment of a cancer, particularly a cancer involving a solid tumour, which comprises the administration of AZD2171 in combination with pemetrexed; to a pharmaceutical composition comprising AZD2171 and pemetrexed; to a combination product comprising AZD2171 and pemetrexed for use in a method of treatment of a human or animal body by therapy; to a kit comprising AZD2171 and pemetrexed; to the use of AZD2171 and pemetrexed in the manufacture of a medicament for use in the production of an antiangiogenic and/or vascular permeability reducing effect in a warm-blooded animal such as a human which is optionally being treated with ionising radiation. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008113039-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007135462-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008125447-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7829573-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003144298-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008269261-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009176731-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011212978-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9746477-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017030923-A1 |
priorityDate |
2005-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |